# Gaojian Ning

> Gaojian Ning is a startup investor at BioVenture. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioVenture](https://shizune.co/investors/profile/bioventure)
- Last updated: Aug 2026

Gaojian Ning is a startup investor at BioVenture. Gaojian Ning - Investment Director @ BioVenture

## About BioVenture

VC Fund · Suzhou, China

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

5 contacts available at BioVenture.

| Name | Title | Profile |
| --- | --- | --- |
| Erik Hoppe | Executive Partner | https://shizune.co/investors/profile/erik-hoppe |
| Chen Jie | Founding Partner | https://shizune.co/investors/profile/chen-jie-281b |
| Gaojian Ning | Investment Director | https://shizune.co/investors/profile/gaojian-ning |
| Haihua Huang | Investment Director | https://shizune.co/investors/profile/haihua-huang |
| Jacky Chen | General Manager | https://shizune.co/investors/profile/jacky-chen |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co